ADVERTISEMENT

Home| Journals| Articles by Year| Audio Abstracts
 

Research Article

Open Vet J. 2026; 16(8): 5422-5433


NAFLD animal model: HFD-C with fructose in male Sprague–Dawley rats

Jenny Novina Sitepu, Hery Djagat Purnomo, Neni Susilaningsih, Udadi Sadhana, Endang Mahati, Banundari Rachmawati.



Abstract
Download PDF Post

Background:
A good animal model was essential to understand the mechanism of NAFLD. It was needed to explore the NAFLD drug candidate target.

Aim:
This study aimed to determine the optimal fructose concentration and induction period for the NAFLD animal model.

Methods:
A total of 28 adult male Sprague Dawley rats were divided randomly into seven groups: standard diet (control, P1), three groups HFD-C with 30% w/v fructose for 4 weeks (P2), 6 weeks (P3), 8 weeks (P4), and three other groups HFD-C with 60% w/v fructose for 4 weeks (P5), 6 weeks (P6), and 8 weeks (P7). The blood sample and liver tissue were collected at the end of each period. We used spectrophotometry to measure the transaminase enzyme and metabolic parameter concentration. Liver tissue was evaluated by steatosis activity and fibrosis (SAF).

Results:
The steatosis of HFD-C with fructose groups (P2, P3, P4, P5, P6, and P7) were significantly higher than control group (P

Key words: Animal model; Fatty liver; NAFLD; Sprague Dawley.







Bibliomed Article Statistics

12
R
E
A
D
S

9
D
O
W
N
L
O
A
D
S
08
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.